Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.
Baba, M, Shigeta, S, Yuasa, S, Takashima, H, Sekiya, K, Ubasawa, M, Tanaka, H, Miyasaka, T, Walker, R T, De Clercq, EVolume:
38
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.38.4.688
Date:
April, 1994
File:
PDF, 1.01 MB
english, 1994